Logo image of PSNYW

POLESTAR AUTO CLASS C-1 ADS (PSNYW) Stock Price, Quote, News and Overview

NASDAQ:PSNYW - Nasdaq - - Currency: USD

0.1685  +0 (+2.12%)

After market: 0.1679 0 (-0.36%)

Fundamental Rating

1

Overall PSNYW gets a fundamental rating of 1 out of 10. We evaluated PSNYW against 41 industry peers in the Automobiles industry. Both the profitability and financial health of PSNYW have multiple concerns. PSNYW is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PSNYW has reported negative net income.
PSNYW had negative earnings in each of the past 5 years.
PSNYW had a negative operating cash flow in each of the past 5 years.
PSNYW Yearly Net Income VS EBIT VS OCF VS FCFPSNYW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -500M -1B -1.5B -2B

1.2 Ratios

PSNYW has a worse Return On Assets (-37.14%) than 70.73% of its industry peers.
Industry RankSector Rank
ROA -37.14%
ROE N/A
ROIC N/A
ROA(3y)-23.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSNYW Yearly ROA, ROE, ROICPSNYW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 -200 -400 -600 -800

1.3 Margins

PSNYW does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSNYW Yearly Profit, Operating, Gross MarginsPSNYW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 50 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

PSNYW does not have a ROIC to compare to the WACC, probably because it is not profitable.
PSNYW has about the same amout of shares outstanding than it did 1 year ago.
PSNYW has a worse debt/assets ratio than last year.
PSNYW Yearly Shares OutstandingPSNYW Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 500M 1B 1.5B 2B
PSNYW Yearly Total Debt VS Total AssetsPSNYW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.82%
PSNYW Yearly LT Debt VS Equity VS FCFPSNYW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 1B -1B -2B

2.3 Liquidity

PSNYW has a Current Ratio of 0.61. This is a bad value and indicates that PSNYW is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of PSNYW (0.61) is worse than 73.17% of its industry peers.
PSNYW has a Quick Ratio of 0.61. This is a bad value and indicates that PSNYW is not financially healthy enough and could expect problems in meeting its short term obligations.
PSNYW's Quick ratio of 0.61 is on the low side compared to the rest of the industry. PSNYW is outperformed by 60.98% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.61
PSNYW Yearly Current Assets VS Current LiabilitesPSNYW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1B 2B 3B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for PSNYW have decreased strongly by -347.20% in the last year.
Looking at the last year, PSNYW shows a very negative growth in Revenue. The Revenue has decreased by -22.12% in the last year.
Measured over the past years, PSNYW shows a very strong growth in Revenue. The Revenue has been growing by 57.38% on average per year.
EPS 1Y (TTM)-347.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.29%
Revenue 1Y (TTM)-22.12%
Revenue growth 3Y57.38%
Revenue growth 5YN/A
Sales Q2Q%-16.43%

3.2 Future

Based on estimates for the next years, PSNYW will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.85% on average per year.
PSNYW is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.91% yearly.
EPS Next Y-36.52%
EPS Next 2Y-6.54%
EPS Next 3Y5.22%
EPS Next 5Y16.85%
Revenue Next Year-14.1%
Revenue Next 2Y23.4%
Revenue Next 3Y31.96%
Revenue Next 5Y34.91%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PSNYW Yearly Revenue VS EstimatesPSNYW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B
PSNYW Yearly EPS VS EstimatesPSNYW Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PSNYW. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PSNYW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSNYW Price Earnings VS Forward Price EarningsPSNYW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSNYW Per share dataPSNYW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.54%
EPS Next 3Y5.22%

More info and screens

0

5. Dividend

5.1 Amount

PSNYW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

POLESTAR AUTO CLASS C-1 ADS

NASDAQ:PSNYW (4/25/2025, 8:00:00 PM)

After market: 0.1679 0 (-0.36%)

0.1685

+0 (+2.12%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)04-14 2025-04-14/amc
Earnings (Next)N/A N/A
Inst Owners4.11%
Inst Owner Change0%
Ins Owners62.98%
Ins Owner ChangeN/A
Market Cap355.59M
Analysts46.15
Price Target0.25 (48.37%)
Short Float %0.01%
Short Ratio0.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.91%
Min EPS beat(2)4.17%
Max EPS beat(2)29.66%
EPS beat(4)3
Avg EPS beat(4)19.61%
Min EPS beat(4)-9.65%
Max EPS beat(4)54.25%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.32%
Min Revenue beat(2)-42.82%
Max Revenue beat(2)-19.82%
Revenue beat(4)0
Avg Revenue beat(4)-25.98%
Min Revenue beat(4)-42.82%
Max Revenue beat(4)-14.8%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.51%
PT rev (3m)16.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.76%
EPS NY rev (1m)12.02%
EPS NY rev (3m)-4.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-29.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.98
BVpS-0.86
TBVpS-0.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.14%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-23.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.61
Altman-Z N/A
F-ScoreN/A
WACC7.82%
ROIC/WACCN/A
Cap/Depr(3y)341.13%
Cap/Depr(5y)402.63%
Cap/Sales(3y)21.26%
Cap/Sales(5y)82.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-347.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.29%
EPS Next Y-36.52%
EPS Next 2Y-6.54%
EPS Next 3Y5.22%
EPS Next 5Y16.85%
Revenue 1Y (TTM)-22.12%
Revenue growth 3Y57.38%
Revenue growth 5YN/A
Sales Q2Q%-16.43%
Revenue Next Year-14.1%
Revenue Next 2Y23.4%
Revenue Next 3Y31.96%
Revenue Next 5Y34.91%
EBIT growth 1Y-68.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.66%
EBIT Next 3Y27.9%
EBIT Next 5Y23.38%
FCF growth 1Y-36.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.66%
OCF growth 3YN/A
OCF growth 5YN/A